Ameriprise’s BIND THERAPEUTICS INC BIND Stock Holding History

Ameriprise’s Portfolio BIND Stock Details BIND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-50	Closed	-$1K	–	6155
2014 Q2	$1K	Buy	+50	New	+$489	﹤0.01%	5498

Other funds holding BIND

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameriprise's BIND Position: Q3 2014 in Review

Ameriprise sold out of BIND THERAPEUTICS INC (BIND) in Q3 2014, closing a stake of 50 shares — an estimated $1K sold.

Ameriprise first reported a position in BIND in Q2 2014 and held it in 1 quarter. The position peaked at $1K in Q2 2014. 40 funds tracked by Wall St. Rank hold BIND as of Q3 2014.

Ameriprise reported no remaining BIND THERAPEUTICS INC position as of Q3 2014 after selling out during the quarter.
Ameriprise sold 50 BIND THERAPEUTICS INC shares in Q3 2014, an estimated $1K.
Ameriprise first reported a position in BIND THERAPEUTICS INC in Q2 2014 and held it in 1 quarter.
Ameriprise's BIND THERAPEUTICS INC position peaked at $1K in Q2 2014.
40 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q3 2014.

Based on Ameriprise's 13F filing for Q3 2014, filed 14 Nov 2014.